Prostate Cancer

  • Most Topular Stories

  • Green Tea Helps Prevent Prostate Cancer in Men with High-Grade PIN

    Healthy Living News from Prostate.net
    Editor
    26 Jan 2012 | 10:04 pm
    Men with high-grade PIN (prostate intraepithelial neoplasia) are at significant risk of developing prostate cancer within one year of undergoing a repeat prostate biopsy. It may be possible to safely and effectively reduce the risk of prostate cancer by taking green tea catechins, according to a study published in Cancer Research. Read more

  • USPTF guidelines – please help!

    Prostate Cancer Advocacy and Action
    Mary
    19 Oct 2011 | 6:10 pm
    Please submit your comments to the USPTF. We need 30,000 by November http://www.uspreventiveservicestaskforce.org/uspstf_form3/

  • MRIs Changed Course of Robotic Surgery

    Prostate Cancer Blog for Wives and Partners
    26 Jan 2012 | 1:18 pm
    When men undergoing robotic-assisted laparoscopic prostatectomy had magnetic resonance imaging (MRI) of the prostate gland prior to their procedures, it changed the surgeon's decision to use a nerve-sparing technique in 27% of men, according to results from a single-center study, published by McClure, et al in the January 24th online edition of Radiology. January 26, 2012.

  • Dutasteride Slows Down Early Stage Prostate Cancer Progression

    Prostate / Prostate Cancer News From Medical News Today
    25 Jan 2012 | 8:00 am
    A study published Online First in The Lancet has found that a common medication (dutasteride) used to treat enlargement of the prostate, may also reduce the need for treatments that pose risks of incontinence and impotence and delay growth of early-stage prostate cancer...

  • Prostate Cancer Online Sexuality Survey Results Now Available

    Prostate Cancer Blog for Wives and Partners
    21 Jan 2012 | 8:06 pm
    Dr. Jo-an Baldwin Peters (PhD) just contacted me to let me know that results of her independent online sexuality survey for prostate cancer survivors and their partners (and other helpful articles) are now available online. Dr. Baldwin and her fellow research partners conducted the survey as a follow up to her earlier work on how prostate cancer treatments impinge on the sexuality of both partners. January 21, 2012.
  • add this feed to my.Alltop

    MedWorm: Prostate Cancer

  • Director's Comments: What's the Ultimate Goal of Prostate Cancer Screening?

    27 Jan 2012 | 11:10 pm
    Listen to the NLM Director's Comments on "What's the Ultimate Goal of Prostate Cancer Screening?". The transcript is also available. Is the goal of prostate cancer screening to increase its detection, or reduce mortality? This question is posed prominently in a comprehensive study of adult men recently published in the Journal of the National Cancer Institute. (Source: What's New on MedlinePlus)MedWorm Sponsor Message: Find the best January Sales in the UK.

  • Brachytherapy Lowers Prostate Cancer Mortality

    27 Jan 2012 | 11:00 am
    According to a study from radiation oncologists at the Kimmel Cancer Center at Jefferson, high-risk prostate cancer patients who receive brachytherapy, alone or together with external beam radiation therapy (EBRT) had considerably lower mortality rates. The study is published online January 23 in the International Journal of Radiation Oncology*Biology*Physics. Brachytherapy is a form of radiotherapy where a radiation source is placed directly at the site of a tumor. The treatment is generally used to treat men with low and intermediate risk prostate cancers... (Source: Health News from…

  • Active surveillance best for prostate cancer?

    27 Jan 2012 | 8:13 am
    (Source: PharmacoEconomics and Outcomes News)

  • Utility of Genome‐Wide Association Study findings: prostate cancer as a translational research paradigm

    27 Jan 2012 | 7:04 am
    AbstractGenomewide Association Studies (GWAS) have identified thousands of consistently replicated associations between genetic markers and complex disease risk, including cancers. Alone, these markers have limited utility in risk prediction; however, when several of these markers are used in combination, the predictive performance appears to be similar to currently many available clinical predictors. Despite this, there are divergent views regarding the clinical validity and utility of these genetic markers in risk prediction. There are valid concerns, thus providing a direction for new…

  • Gene expressional changes in prostate fibroblasts from cancerous tissue

    27 Jan 2012 | 2:28 am
    Prostate cancer is the most common type of cancer in men. It is assumed that the tumor microenvironment of the prostate contributes to invasion and metastasis. Stroma‐epithelial crosstalk has shown to change with progression of prostate cancer, and thereby the stromal compartment might be an attractive target in diagnostic and therapeutic approaches to prostate cancer. The purpose of this project was to study the reciprocal influence between fibroblasts and cancer cells in prostate cancer. Prostate fibroblast primary cultures from areas with cancer and hyperplasia were cocultivated with…
 
  • add this feed to my.Alltop

    MedWorm Query: prostate cancer

  • ‘Significant minority’ of patients continue smoking after cancer diagnosis

    27 Jan 2012 | 3:03 am
    US researchers report that a “significant minority” of patients diagnosed with lung or colorectal cancer are still smoking 5 months after they received their diagnosis. (Source: MedWire News - Respiratory)

  • The science behind the 7th edition Tumour, Node, Metastasis staging system for lung cancer

    27 Jan 2012 | 3:00 am
    ABSTRACTThe Tumour, Node, Metastasis (TNM) system for classifying lung cancer is the cornerstone of modern lung cancer treatment and underpins comparative research; yet is continuously evolving through updated revisions. The recently published Union for International Cancer Control 7th Edition TNM Classification for lung cancer addresses many of its predecessor's shortcomings and has been subject to rigorous evidence‐based methodology. It is based on a retrospective analysis of over 80 000 lung cancer patients treated between 1990 and 2000 carried out by the International Association for…

  • Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy

    27 Jan 2012 | 2:37 am
    Authors: Guangbo Chen, William D. Bradford, Chris W. Seidel & Rong Li Aneuploidy—the state of having uneven numbers of chromosomes—is a hallmark of cancer and a feature identified in yeast from diverse habitats. Recent studies have shown that aneuploidy is a form of large-effect mutation that is able to confer adaptive phenotypes under diverse stress conditions. Here we investigate whether pleiotropic stress could induce aneuploidy in budding yeast (Saccharomyces cerevisae). We show that whereas diverse stress conditions can induce an increase in chromosome instability,…

  • Gene expressional changes in prostate fibroblasts from cancerous tissue

    27 Jan 2012 | 2:28 am
    Prostate cancer is the most common type of cancer in men. It is assumed that the tumor microenvironment of the prostate contributes to invasion and metastasis. Stroma‐epithelial crosstalk has shown to change with progression of prostate cancer, and thereby the stromal compartment might be an attractive target in diagnostic and therapeutic approaches to prostate cancer. The purpose of this project was to study the reciprocal influence between fibroblasts and cancer cells in prostate cancer. Prostate fibroblast primary cultures from areas with cancer and hyperplasia were cocultivated with…

  • Metastatic endocervical adenocarcinoma in a western lowland gorilla (Gorilla g. gorilla) – no evidence of virus‐induced carcinogenesis

    27 Jan 2012 | 2:28 am
    Conclusions  Histopathologically and immunohistochemically, the tumour had striking similarities to human endocervicial adenocarcinomas of the common type. However, PCR analysis failed to identify herpes‐ or papillomaviral DNA in the tumor at the time of necropsy, thus leaving the question for cause of the disease open. (Source: Journal of Medical Primatology)
  • add this feed to my.Alltop

    MedWorm: Hormone Refractory Prostate Cancer

  • NICE FAD does not recommend cabazitaxel for the second line treatment of prostate cancer

    11 Jan 2012 | 10:00 pm
    Source: NICE Area: News NICE has issued a Final Appraisal Determination (FAD) on the use of cabazitaxel for the second line treatment of hormone refractory, metastatic prostate cancer.   The FAD does not recommend cabazitaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.   In a related press release, the Chief Executive of NICE said, "We need to be sure that new treatments provide sufficient benefits to patients to justify the significant resources the NHS…

  • Indication Of Considerable Added Benefit From Abiraterone In Certain Prostate Cancer Patients

    10 Jan 2012 | 1:00 am
    Advantages for men with metastatic hormone-refractory prostate cancer who are no longer eligible for docetaxel therapy Abiraterone (trade name: Zytiga®) has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic drug docetaxel... (Source: Health News from Medical News Today)

  • [How should hormone therapy for castration-resistant prostate cancer be continued?].

    31 Dec 2011 | 10:00 pm
    Authors: Spahn M, Krebs M Abstract After an average of 18-36 months under androgen suppression therapy by surgical castration, LHRH, and steroidal or non-steroidal antiandrogens, almost all patients with metastatic prostate cancer show PSA progression as a sign of androgen-independent but still androgen-sensitive tumor growth. Our understanding and the treatment of such castration-resistant prostate cancer has changed markedly. The introduction of new drugs like abiraterone and MDV3100 has shown that prostate cancer progression even in the"hormone-refractory" stage is driven by androgen…

  • Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide

    27 Dec 2011 | 9:51 am
    We report a patient who improved following intra-arterial infusion of cisplatin (CDDP) and ifosfamide (IFM) to treat urinary retention caused by locally recurring HRPC. After chemotherapy, cancer volume was remarkably reduced and symptoms improved. Content Type Journal ArticleCategory Case ReportPages 1-3DOI 10.1007/s10156-011-0352-9Authors Keiichiro Uemura, Department of Urology, Kurume University School of Medicine, Asahimach 67, Kurume, Fukuoka, JapanKiyoaki Nishihara, Department of Urology, Kurume University School of Medicine, Asahimach 67, Kurume, Fukuoka, JapanTokumasa Hayashi,…

  • Inhibition of IGF-1 Signaling by Genistein: Modulation of E-Cadherin Expression and Downregulation of β-Catenin Signaling in Hormone Refractory PC-3 Prostate Cancer Cells.

    17 Nov 2011 | 10:00 pm
    Authors: Lee J, Ju J, Park S, Hong SJ, Yoon S Abstract Elevated levels of insulin-like growth factor-1 (IGF-1) are associated with an increased risk of several different cancers, including prostate cancer. Inhibition of IGF-1 and the downstream signaling pathways mediated by the activation of the IGF-1 receptor (IGF-1R) may be involved in inhibiting prostate carcinogenesis. We investigated whether genistein downregulated the IGF-1/IGF-1R signaling pathway and inhibited cell growth in hormone refractory PC-3 prostate cancer cells. Genistein treatment caused a significant inhibition of…
 
  • add this feed to my.Alltop

    prostate cancer - stories: just in

  • Analyze this – prostate cancer research

    YankeeJim
    7 Jan 2012 | 7:43 am
    Analyze this – prostate cancer researchWarning: This article may make some people uncomfortable.  A whole bunch of men over 55 eventually meet their prostate. It is supposed to be the size of a walnut, but...read more

  • Prostate Cancer Market will be USD 24.9 Billion by 2016

    glenajess
    25 Nov 2011 | 7:21 am
    According to a new report published by Transparency Market Research (http://www.transparencymarketresearch.com)"North America & Europe Minimally Invasive Prostate Cancer Surgery Market (2011 - 2016) " the prostate cancer minimally invasive surgical device market in...read more

  • Scaring Men Healthy: Pokey Czechs & Models with Testicles

    AdFool
    14 Oct 2011 | 5:22 pm
    For guys, getting old can actually be a good thing. Bad eyes and worse hearing can provide welcome relief from the sights and sounds of everyday idiots. Plus you’re never expected to change your mind about...read more

  • Movember Replaces November: Grow A Moustache For Prostate Cancer

    NowPublic Staff
    20 Oct 2010 | 2:39 pm
    Mo Bros Step Up: Movember 2010, Raise Money And Awareness In November For Prostrate Cancer The statistics are startling - one in six men will get prostrate cancer so that why November is being called Movember. The...read more

  • Global Economic Tsunami - The Sith Lords Cometh

    RoryKearney
    20 Feb 2010 | 10:02 am
    Double, double toil and trouble; Fire burn, and cauldron bubble. William Shakespeare, "Macbeth", Act 4 scene 1 http://www.quotationspage.com/quote/25292.html   Double Trouble Indeed! I read an exciting...read more
 
  • add this feed to my.Alltop

    Prostate Cancer - Articles - Zimbio

  • Movember NZ 2010 TV Promo Clip 30 seconds

    27 Jan 2012 | 8:51 pm
    Hi,I did the following: Movember NZ 2010 TV Promo Clip 30 seconds Video Rating: 4 / 5 Read about prostate cancer symptoms, causes, prevention, treatment options, staging, screening and diagnosis. Living in the Heart of Virginia : Prostate Health Navigators August 17, 2010 — Meet Jerilyn Becker, a Prostate Health Navigator from Centra. Jerilyn talks with Tab about what happens during a typical visit and how Navigators such as herself establish and build a relationship with each patient. During the development of that relationship Navigators are instrumental in providing educational…

  • Sex, Prostate Cancer & Me: A wife’s chronicle of her husband’s prostate cancer diagnosis, radical prostatectomy & sexual recovery

    27 Jan 2012 | 3:45 am
    Sex, Prostate Cancer & Me: A wife’s chronicle of her husband’s prostate cancer diagnosis, radical prostatectomy & sexual recovery Every year in the US, approximately 220,000 men receive a diagnosis of prostate cancer. Sex, Prostate Cancer & Me takes the reader on a journey with the author and her husband as they negotiate the process, from diagnosis, to overcoming the effects of a radical prostatectomy on their sex life. Ms. McDowell offers hope, as well as suggestions, for couples concerned about intimacy after surgery. Hers is a forthright and personal narrative.

  • ProstateHealthAnswers.com Addresses Concerns Facing Men with Urological Issues

    27 Jan 2012 | 2:00 am
    (EMAILWIRE.COM, January 27, 2012 ) Morrisville, PA -- Bucks County, Pennsylvania – MediCom Worldwide, Inc., a leading medical education company, announced today the launch of a new website to deal with mens’ urological issues, including prostate health. The site is known as Prostate Health Answers,...

  • ProstaCaid™ inhibits tumor growth in a xenograft model of human prostate cancer

    26 Jan 2012 | 4:45 pm
    Authors Jiahua Jiang, Jagadish Loganathan, Isaac Eliaz, Colin Terry, George E. Sandusky, Daniel Sliva – Cancer Research Laboratory, Methodist Research Institute, Indiana University Health, Indianapolis, IN, USA, Amitabha Medical Clinic and Healing Center, Sebastopol, CA, USA, Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA Publication Published online on: Tuesday, January 24, 2012. Doi: 10.3892/ijo.2012.1344 Abstract We have recently demonstrated that the dietary supplement ProstaCaid™ (PC) inhibits growth and invasive behavior of PC-3 human…

  • Sabona Arnie’s Army Battles Prostate Cancer Awareness Magnetic Bracelet (Stainless/Black, X-Large /8.0)

    26 Jan 2012 | 3:52 am
    Sabona Arnie’s Army Battles Prostate Cancer Awareness Magnetic Bracelet (Stainless/Black, X-Large /8.0) 1200 gauss magnets Brushed and polished stainless steel Sabona guarantees this bracelet against any manufacturing defect for a period of 6 months. For more information on our warranty, please call 800-497-4199 This bracelet features a stylish combination of brushed and polished stainless steel and a 1200 gauss magnet in each link. A portion of the sales of this bracelet will be donated to the Prostate Cancer Foundation, an organization firmly committed to curing prostate cancer. To…
  • add this feed to my.Alltop

    THE "NEW" PROSTATE CANCER INFOLINK

  • AHRQ responds to letter from Prostate Cancer Roundtable

    Sitemaster
    27 Jan 2012 | 4:10 pm
    Members of the Prostate Cancer Roundtable have received a letter from the Agency for Healthcare Research and Quality (AHRQ) addressing issues raised by the Roundtable members about the draft USPSTF recommendations on use of the PSA test in screening for risk of prostate cancer. The letter from Dr. Carolyn Clancy makes no comments or commitments [...]

  • The walnuts are back in vogue (at least with mice)

    Sitemaster
    26 Jan 2012 | 9:16 am
    According to a media release we received yesterday, a new paper in the British Journal of Nutrition suggests that “walnuts may help to prevent prostate cancer risk.” Of course what the study actually shows is that … prostate tumors in mice fed the human equivalent of three ounces per day of walnuts were approximately 50% [...]

  • Sebelius has NOT overruled USPSTF recommendation after all

    Sitemaster
    25 Jan 2012 | 8:42 am
    For our US-based readers … It appears that Rep. Kucinich’s statements on his web site (reported on this web site a few days ago) are something of a political simplification of reality. On December 9, 2011, Secretary Sebelius sent this letter to Rep. Kucinich and his colleagues. The letter contains the following statement (in specific reference [...]

  • The value of MRI prior to surgery as a treatment for localized prostate cancer

    Sitemaster
    25 Jan 2012 | 8:21 am
    A recent media release from the Radiological Society of North America (RSNA) is headed, “Preoperative MRU may reduce risk of nerve damage in prostate cancer surgeries” … and this is absolutely true. The problem, however, is that it is only appears to be true for about a quarter of all the men undergoing surgery, so [...]

  • Dutasteride as a single agent for low-risk prostate cancer

    Sitemaster
    24 Jan 2012 | 7:59 pm
    According to data just reported in The Lancet, some men with low-volume, low-risk prostate cancer may be able to delay progression of their disease if treated only with the 5α-reductase inhibitor dutasteride (Avodart®). Fleshner et al. conducted a multi-center, randomized, double-blind, placebo-controlled trial (the REDEEM trial) in men aged between 48 and 82 years who [...]
 
  • add this feed to my.Alltop

    About.com Prostate Cancer: What's Hot Now

  • EBRT Side Effects

    prostatecancer.guide@about.com
    28 Jan 2012 | 5:14 am
    It is important to understand the potential side effects that may result from external beam radiation therapy (EBRT) for prostate cancer.

  • Digital Rectal Exam

    prostatecancer.guide@about.com
    28 Jan 2012 | 5:14 am
    The digital rectal exam is an essential part of the detection and early diagnosis of prostate cancer. Many men are worried about this test, so it's important to know what to expect.

  • Radical Prostatectomy

    prostatecancer.guide@about.com
    28 Jan 2012 | 5:14 am
    What Is Radical Prostatectomy? There are two primary active treatment options for early prostate cancer

  • Prostate Cancer Warning Signs

    prostatecancer.guide@about.com
    28 Jan 2012 | 5:14 am
    Are there prostate cancer warning signs? Are there signs and symptoms that could point to underlying prostate cancer? What are some prostate cancer warning signs?

  • Complications Overview

    prostatecancer.guide@about.com
    28 Jan 2012 | 5:14 am
    Unfortunately, for many men who have undergone treatment for prostate cancer, complications of their treatment is a fact of life. What are the most frequent complications that can occur following the standard prostate cancer treatments?
  • add this feed to my.Alltop

    About.com: Prostate Cancer

  • Will I Be Radioactive?

    28 Jan 2012 | 6:04 am
    Will I be radioactive after radiation therapy?

  • What Is Cryotherapy for Prosta

    28 Jan 2012 | 6:04 am
    Cryotherapy is a form of treatment for prostate cancer in which the cancerous cells are destroyed through freezing. What do you need to know about this important alternative therapy?

  • High PSA Causes

    28 Jan 2012 | 6:04 am
    What are some other causes of an elevated PSA? Thousands of men each year are told that they have a high PSA level after undergoing a routine screening test. The most important and most concerning cause of an elevated PSA is prostate cancer. However, prostate cancer is only one of many potential causes of an elevated PSA.

  • Minimally Invasive Surgery

    28 Jan 2012 | 6:04 am
    Minimally invasive prostate surgery has been used extensively for the treatment of prostate cancer, and its use continues to grow. What does minimally invasive prostate surgery entail?

  • What Is BPH?

    28 Jan 2012 | 6:04 am
    Benign prostatic hyperplasia (BPH) or "enlarged prostate" is a condition that can cause many of the same
  • add this feed to my.Alltop

    Malecare's Advanced Prostate Cancer

  • OncoGenex To Present OGX-427 Data At ASCO 2012 Genitourinary Cancers Symposium

    Joel
    23 Jan 2012 | 10:24 am
    Maybe we are about to have another new treatment for advanced prostate cancer that will earn the coveted descriptor, “ON THE HORIZON.” OncoGenex Pharmaceuticals Inc. (OGXI) has said that they will be presenting preliminary data from their phase 2 trials evaluating their investigational compound OGX-427, in prostate and bladder cancer. The data will be presented at the American Society of Clinical Oncology ( ASCO) 2012 Genitourinary Cancers Symposium which will be held on February 2-4, in San Francisco. OGX-427 is a novel compound designed to reduce levels of Heat Shock Protein 27 (Hsp27)…

  • The Value of Evaluating Circulating Tumor Cells – Better Survival Predictions

    Joel
    18 Jan 2012 | 7:18 pm
    The use of the PSA as a prostate cancer screening tool has been a controversial issue for many years. Within the last year the issue has again come to the forefront of the public awareness, especially because of the recent move of the U.S Preventative Task Force to discourage using the PSA as a screening tool . One of the ways that has been used to approach this question is to develop a better bio-marker to serve both as a screening tool and as a predictor of the responsiveness to treatment. If such a marker could be identified, we could make better decisions about who should be treated and…

  • Bavarian Nordic Initiates Pivotal Phase 3 Trial of PROSTVAC® Prostate Cancer Immunotherapy

    Joel
    17 Jan 2012 | 10:14 am
    Bavarian Nordic A/S (BAVA) announced on November 15, that its subsidiary, BN ImmunoTherapeutics has started the pivotal Phase 3 trial of PROSTVAC® for men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer. The trial is being conducted under a Special Protocol Assessment agreement with the FDA. Notice this trial has the same criteria as the phase 3 trial of Provenge. Although there are a number of on-going phase 2 trials, BAVA has now opened their first site in the U.S. for this phase 3 trial. There will be a number of other sites and countries to…

  • Estrogen May Play Role in Melanoma Recurrence- A Warning for Those of Us Who Are Considering Estrogen as a Second Line ADT

    Joel
    14 Jan 2012 | 11:53 am
    According to a an article published in the January 2012 issue of Cancer Prevention Research, estrogen may play a role in Melanoma recurrences! The article described a large cohort study of women who were put on an anti-estrogen therapy. The study concluded that those women on the anti-estrogen therapy had a lower risk of melanoma. About the Study: • It included 7,360 women who were diagnosed with breast cancer between 1980 and 2005. • Fifty four percent (54% ) of the women were given supplemental anti-estrogen therapy. • The surprise finding was that the rate of melanoma was 60% higher…

  • Fighting Infections while on Chemotherapy – Using Neulasta

    Joel
    12 Jan 2012 | 10:45 am
    Neulasta (Pegfilgrastim) is used to reduce the chance of infection in people who have certain cancers and are also receiving chemotherapy medications, including taxotere for men being treated for advanced prostate cancer. Chemotherapy is designed to kill fast growing cells. However, it can’t tell the difference between cancer cells and fast-growing healthy cells, including red and white blood cells. (This is why men can lose their hair and have damage to their nails since they are among the faster growing of our healthy cells). As a result, one of the most serious potential side effects of…
 
  • add this feed to my.Alltop

    Prostate Cancer Advocacy and Action

  • The forest through the trees

    Mary
    21 Jan 2012 | 2:18 pm
    In December of 2011 the National Institute of Health (NIH) released a draft State-of-the-Science Conference Statement.  The focus of the study was on PSA-based screening which has identified many men with low-risk prostate cancer.  Over the past decade active surveillance has emerged as a viable option for men with low-risk prostate cancer. This represents approximately 100,000 men diagnosed in the United States each year.  Despite the very favorable prognosis of low-risk prostate cancer, many men with low-risk disease continue to opt for or are only offered treatments such as radical…

  • NIH Conference on Active Surveillance Summary

    Mary
    28 Dec 2011 | 5:18 pm
    I’d like to invite everyone to read an article by Gary Schwitzer which nicely summarizes some interesting ideas relating to the concept of Active Surveillance originally posted on healthnewsreviews.org.  Any discussion is very welcome!

  • PSA + big picture = Men’s Health Night

    Mary
    19 Nov 2011 | 10:15 am
    It’s interesting to reflect on the recent USPTF PSA upheaval – and to consider how and why we are here from a position of compassion. Personally, I’m interested and involved because my dad died of aggressive prostate cancer. He was screening – back in 1996 when screening was gaining momentum as a tool to find cancer early. The antiquated PSA threshold for a man of his age during that time period missed his cancer. He was in his late 40s (with a PSA of just under 4). His cancer was found several years later… only then it was too late for him. Modern standards for…

  • 11/8 – big policy day…

    Mary
    7 Nov 2011 | 8:01 pm
    Tomorrow is our last to comment on the USPTF draft recommendations for PSA. Now – more than ever, please consider who you vote for and what they stand for… look deeper than peacock posturing and flashy promises. What has this person done for the people they’ve been responsible to in the past? Are they bought and paid for? And where do they really stand on the issues that matter to you? If it takes 5 minutes to vote – you’re not doing it right…

  • USPTF guidelines – please help!

    Mary
    19 Oct 2011 | 6:10 pm
    Please submit your comments to the USPTF. We need 30,000 by November http://www.uspreventiveservicestaskforce.org/uspstf_form3/
  • add this feed to my.Alltop

    prostate-report.org

  • Brachytherapy reduced death rates in high-risk prostate cancer patients

    Admin
    27 Jan 2012 | 7:57 am
    A new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests that brachytherapy for high-risk prostate cancers patients is very effective modality. A population-based analysis looking at almost 13,000 cases revealed that men who received brachytherapy alone or in combination with external beam radiation therapy (EBRT) had significantly reduced mortality rates.

  • Men’s hopes for robot prostate surgery unrealistic

    Admin
    26 Jan 2012 | 9:29 am
    Robot-assisted surgery for prostate cancer has been heavily hyped, and a new study suggests that men’s expectations of the surgery may be too high.Researchers found that of 171 men facing prostate cancer surgery, those having robotic surgery expected a shorter hospital stay, and a quicker return to their usual physical activity and sex life. But those hopes may not be realistic.

  • Preoperative MRI may reduce risk of nerve damage in prostate cancer surgeries

    Admin
    25 Jan 2012 | 2:10 pm
    According to a new study at the Centers for Disease Control and Prevention, preoperative MRI helps surgeons make more informed decisions about nerve-sparing procedures in men with prostate cancer. For the approach to become more commonplace two things are needed: a better way to stratify which patients would benefit from preoperative MRI, and a more standardized means of acquiring and interpreting prostate MRI results. Stusy is published online in the journal Radiology.

  • Prostate cancer study proves the drug dutasteride delays disease progression

    Admin
    23 Jan 2012 | 9:29 pm
    Good news coming from University Health Network for men diagnosed with low-risk, localized prostate cancer. Results of a three-year international clinical trial show that being treated with the drug dutasteride (”Avodart”) delays disease progression and initiating active treatment, and also reduces anxiety. Researchers say that trial results prove that using active surveillance plus dutasteride is a viable, safe and effective treatment option for men who often undergo aggressive local treatment despite low risk of dying from the disease. Best news is patients can avoid aggressive…

  • Robotic surgery promises greater precision, less blood loss

    Admin
    22 Jan 2012 | 12:21 pm
    The reason robotics really took off was the blood loss. A traditional “open” pelvic surgery uses 2 liters of blood (approximately one-half gallon) versus 100 cubic centimeters (approximately 3 ounces) for the minimally invasive, robotically assisted surgery. Once, during a particularly difficult open surgery, he saw a patient require 22 liters of blood. In addition to reducing blood loss, the system reduces recovery time, pain and trauma by minimizing the number and size of the incisions needed for the surgery.
  • add this feed to my.Alltop

    Prostate Cancer Blog for Wives and Partners

  • MRIs Changed Course of Robotic Surgery

    26 Jan 2012 | 1:18 pm
    When men undergoing robotic-assisted laparoscopic prostatectomy had magnetic resonance imaging (MRI) of the prostate gland prior to their procedures, it changed the surgeon's decision to use a nerve-sparing technique in 27% of men, according to results from a single-center study, published by McClure, et al in the January 24th online edition of Radiology. January 26, 2012.

  • Prostate Cancer Online Sexuality Survey Results Now Available

    21 Jan 2012 | 8:06 pm
    Dr. Jo-an Baldwin Peters (PhD) just contacted me to let me know that results of her independent online sexuality survey for prostate cancer survivors and their partners (and other helpful articles) are now available online. Dr. Baldwin and her fellow research partners conducted the survey as a follow up to her earlier work on how prostate cancer treatments impinge on the sexuality of both partners. January 21, 2012.

  • Prostate Cancer Questions and Answers

    21 Jan 2012 | 10:01 am
    This list of common prostate cancer questions and answers makes it easy for you to quickly understand the disease and find key topics you want to learn more about on our site.

  • Why Do Couples Stop Using ED Drugs?

    12 Jan 2012 | 12:38 pm
    Between 15% to 60% of couples stop using oral medications for erectile dysfunction (ED). Moskovic, et al, conducted 155 interviews to determine why couples stop using them in a study that was published in the International Journal of Impotence Research.Thirty-four percent of men said their main reason for stopping usage of ED medication was cost. "Partner issues" from the men's perspective were seldom discussed. For women, however, "partner issues" meant a range of problems from separation to alcohol abuse, lack of communication, lack of confidence, or fear of failure. The authors concluded…

  • Penile Rehabilitation for Erection Problems After Prostate Cancer

    12 Jan 2012 | 11:52 am
    Learn what penile rehabilitation is, and why it’s a hot topic in the prostate cancer medical community.
 
  • add this feed to my.Alltop

    Healthy Living News from Prostate.net

  • Vitamin D Linked to Lower Risk of Colorectal Cancer

    Editor
    26 Jan 2012 | 10:09 pm
    High levels of vitamin D in the bloodstream has been linked to a lower risk of colorectal cancer. Among the findings in the new study was the observation that vitamin D levels interacted with specific areas of the vitamin D receptor gene, with increased vitamin D levels linked to even greater reductions in the risk of colorectal cancer. Read more

  • Walnuts May Help Fight Prostate Cancer

    Editor
    26 Jan 2012 | 10:08 pm
    It may be time to make walnuts a regular part of your diet if you want to help fight prostate cancer. A new study from researchers in California notes that feeding mice the equivalent of 3 ounces of walnuts per day resulted in a 50% reduction in the size of prostate cancer tumors and a 30% slowing in the growth of prostate tumors. Read more

  • Green Tea, Onions and Olive Leaf Help Fight Heart Disease

    Editor
    26 Jan 2012 | 10:06 pm
    Green tea, onions, and olive leaf extract: no, it’s not a recipe but it is a list of natural substances that can help fight heart disease by assisting with weight loss and obesity. A researcher from the University of Southern Queensland reported that green tea and other foods fed to rats experienced a decline in fat cells and lost weight. Read more

  • Green Tea Helps Prevent Prostate Cancer in Men with High-Grade PIN

    Editor
    26 Jan 2012 | 10:04 pm
    Men with high-grade PIN (prostate intraepithelial neoplasia) are at significant risk of developing prostate cancer within one year of undergoing a repeat prostate biopsy. It may be possible to safely and effectively reduce the risk of prostate cancer by taking green tea catechins, according to a study published in Cancer Research. Read more

  • Erectile Dysfunction Drug Seized From Flight

    Editor
    14 Jan 2012 | 3:09 pm
    A pair of socks, a change of underwear and 63 pounds of erectile dysfunction drug. Those were the contents of a man’s luggage as he attempted to enter Los Angeles International Airport from Seoul, South Korea, earlier this month, officials said. “We’ve seen small quantities before, but we’ve never seen 63 pounds,” said Jaime Ruiz with the U.S. Customs and Border Protection. Read more Source: Erectile Dysfunction Drug Seized From Flight | NBC San Diego
Log in